Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
3.555
-0.081 (-2.22%)
At close: Apr 2, 2026, 4:00 PM EDT
3.620
+0.065 (1.82%)
After-hours: Apr 2, 2026, 5:22 PM EDT

Alterity Therapeutics Revenue

Alterity Therapeutics had revenue of 2.80M AUD in the half year ending December 31, 2025, with 47.49% growth. This brings the company's revenue in the last twelve months to 8.84M, up 137.32% year-over-year. In the fiscal year ending June 30, 2025, Alterity Therapeutics had annual revenue of 7.64M with 90.12% growth.

Revenue (ttm)
8.84M AUD
Revenue Growth
+137.32%
P/S Ratio
15.27
Revenue / Employee
982,113 AUD
Employees
9
Market Cap
67.60M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20257.64M3.62M90.12%
Jun 30, 20244.02M102.95K2.63%
Jun 30, 20233.92M-1.21M-23.56%
Jun 30, 20225.12M638.30K14.23%
Jun 30, 20214.49M4.36M3,554.58%
Jun 30, 2020122.73K-4.83M-97.52%
Jun 30, 20194.95M1.83M58.40%
Jun 30, 20183.13M103.10K3.41%
Jun 30, 20173.02M-1.87M-38.27%
Jun 30, 20164.90M-1.60M-24.61%
Jun 30, 20156.49M-1.71M-20.89%
Jun 30, 20148.21M3.57M76.94%
Jun 30, 20134.64M2.11M83.56%
Jun 30, 20122.53M2.36M1,451.38%
Jun 30, 2011162.92K-52.09K-24.23%
Jun 30, 2010215.01K-213.19K-49.79%
Jun 30, 2009428.19K-62.92K-12.81%
Jun 30, 2008491.11K-16.32K-3.22%
Jun 30, 2007507.44K-542.85K-51.69%
Jun 30, 20061.05M-1.60M-60.41%
Jun 30, 20052.65M--